ABSTRACT Background Clinical guidelines, such as NICE NG123, prior to OnabotulinumtoxinA (BoNT‐A) injections for overactive bladder (OAB), patients are counselled regarding clean intermittent self‐catheterisation (CISC) and are willing and able to perform catheterisation if required. Subsequently, universal pre‐procedure education imposes a significant
Faysal elzawy +5 more
wiley +1 more source
Perioperative Outcomes in Simple Cystectomy for Neurogenic Lower Urinary Tract Dysfunction: A Comparison of Surgical Approach, Surgical Teams, and Alvimopan Use. [PDF]
Mundra V +5 more
europepmc +1 more source
ABSTRACT Background Pelvic organ prolapse (POP) frequently coexists with overactive bladder (OAB) symptoms, yet the impact of surgical correction on OAB outcomes remains incompletely characterized across different surgical approaches. Objectives To quantify OAB symptom resolution rates following POP surgery, compare outcomes across surgical techniques,
Lorenzo Vacca +7 more
wiley +1 more source
Functional Magnetic Stimulation in the Management of Lower Urinary Tract Dysfunction in Children with Asperger Syndrome: A Case Report. [PDF]
Frunda EA +9 more
europepmc +1 more source
Fear‐Avoidance and Overactive Bladder: Toward a Mechanism‐Informed Model of Care
ABSTRACT Aims Overactive bladder (OAB) is associated with substantial psychological burden, yet existing biopsychosocial frameworks acknowledge that psychological factors shape outcomes without explaining the cognitive and behavioral mechanisms through which that influence operates.
Rupal M. Patel, Andrea Wood
wiley +1 more source
Genetic Contributions to Lower Urinary Tract Dysfunction. [PDF]
Hiltebeitel LR +10 more
europepmc +1 more source
Diagnosis of Urethral Resistance in Men: 70 Years of History
ABSTRACT Background and Aims The urethral resistance (UR) is one of the key outcomes of the urodynamic pressure‐flow study (PFS) in men. Combined with a clinical meaningful cut‐off point, urodynamic bladder outflow obstruction (BOO) can be determined. This characterization of BOO provides guidance in the management of lower urinary tract symptoms (LUTS)
Wouter van Dort +2 more
wiley +1 more source
Evaluating the Lower Urinary Tract Dysfunction Research Network Symptom Index-29 and SI-10 for Lower Urinary Tract Symptom Assessment Against with the International Prostate Symptom Score: A Cross-Cultural Validation and Agreement Study. [PDF]
Jiraanankul V +6 more
europepmc +1 more source
Abstract Background Efgartigimod disrupts the recycling of pathogenic IgG autoantibodies and may represent a candidate therapy for autoimmune encephalitis. This real‐world study evaluated the clinical efficacy, safety, and impact of efgartigimod on brain inflammation.
Huanyu Meng +12 more
wiley +1 more source
Noninvasive monitoring of lower urinary tract dysfunction in rats with bladder outlet obstruction using uroflowmetry and ultrasonography. [PDF]
Matsuoka K +11 more
europepmc +1 more source

